{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:18:38Z","timestamp":1787851118616,"version":"build-2784847793"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2023C060YLL"],"award-info":[{"award-number":["CI2023C060YLL"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jep.2024.119238","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T12:36:13Z","timestamp":1734784573000},"page":"119238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antiviral activity of HuaganJiedu decoction (HGJDD) against hepatitis B virus (HBV) through FOXO4\/ERK\/HNF4\u03b1 signal pathway"],"prefix":"10.1016","volume":"340","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4788-1768","authenticated-orcid":false,"given":"Hongxuan","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rendong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2024.119238_bib1","first-page":"621","article-title":"Clinical effect evaluation of Hugan detoxification decoction combined with interferon in the treatment of hepatitis B. West. China","volume":"21","author":"Chen","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jep.2024.119238_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/apt.14801","article-title":"Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience","volume":"48","author":"Chen","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jep.2024.119238_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/jvh.12112","article-title":"Anti-HBV effect of individual traditional Chinese herbal medicine in vitro and in vivo: an analytic review","volume":"20","author":"Chen","year":"2013","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.jep.2024.119238_bib4","first-page":"39","article-title":"Traditional Chinese medicine and related active compounds against hepatitis B virus infection","volume":"4","author":"Cui","year":"2010","journal-title":"Biosci. Trend."},{"key":"10.1016\/j.jep.2024.119238_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.lfs.2017.05.015","article-title":"Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1\/2 pathway and down-regulating HNF4\u03b1 and HNF1\u03b1 in vitro","volume":"180","author":"Dai","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.jep.2024.119238_bib6","doi-asserted-by":"crossref","first-page":"22800","DOI":"10.1074\/jbc.M110.105593","article-title":"The ERK1\/2-hepatocyte nuclear factor 4alpha axis regulates human ABCC6 gene expression in hepatocytes","volume":"285","author":"de Boussac","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jep.2024.119238_bib7","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.jep.2024.119238_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jep.2024.119238_bib9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.24505","article-title":"Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner","volume":"54","author":"Han","year":"2011","journal-title":"Hepatology"},{"issue":"Suppl. 2","key":"10.1016\/j.jep.2024.119238_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jvh.12120","article-title":"The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference","volume":"20","author":"Hatzakis","year":"2013","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.jep.2024.119238_bib11","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1128\/MCB.00297-06","article-title":"Mitogen-activated protein kinase-mediated disruption of enhancer-promoter communication inhibits hepatocyte nuclear factor 4alpha expression","volume":"26","author":"Hatzis","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jep.2024.119238_bib12","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/HEP.0000000000000459","article-title":"Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase","volume":"78","author":"Huang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2024.119238_bib13","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1242\/jcs.001222","article-title":"Dynamic FoxO transcription factors","volume":"120","author":"Huang","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jep.2024.119238_bib14","first-page":"1","article-title":"Academician chen kaixiantalks about the development of traditional Chinese medicine and global medicine","volume":"6","author":"Kaixian","year":"2020","journal-title":"World J. Tradit. Chin. Med."},{"key":"10.1016\/j.jep.2024.119238_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jhep.2024.02.033","article-title":"Sex and ethnic disparities in hepatitis B evaluation and treatment across the world","volume":"81","author":"Kudaravalli","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jep.2024.119238_bib16","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/17474124.2023.2268503","article-title":"A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments","volume":"17","author":"Laup\u00e8ze","year":"2023","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2024.119238_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jhep.2016.12.024","article-title":"Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B","volume":"66","author":"Leboss\u00e9","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jep.2024.119238_bib18","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3389\/fimmu.2018.02080","article-title":"Inhibition of HBV expression in HBV transgenic mice using AAV-delivered CRISPR-SaCas9","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jep.2024.119238_bib19","first-page":"73","article-title":"Clinical study of Huaganjiedu Decoction combined with Entecavir in the treatment of chronic viral hepatitis B","volume":"18","author":"Li","year":"2018","journal-title":"Pract. Clin. Integr. J. Chin. West. M\u00e9d."},{"key":"10.1016\/j.jep.2024.119238_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104568","article-title":"FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4\u03b1","volume":"170","author":"Li","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jep.2024.119238_bib21","first-page":"63","article-title":"Zhou Zhongying\u2019s experience in treating hepatitis B with Huagan Jiedu decoction","volume":"27","author":"Liu","year":"2010","journal-title":"Med. Res. Educ."},{"key":"10.1016\/j.jep.2024.119238_bib22","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/hep.29323","article-title":"Hepatitis B cure: from discovery to regulatory approval","volume":"66","author":"Lok","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2024.119238_bib23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.cgh.2018.10.012","article-title":"Poor adherence to guidelines for treatment of chronic hepatitis B virus infection at primary Care and referral practices","volume":"17","author":"Nguyen","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2024.119238_bib24","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.tips.2022.09.010","article-title":"FOXO transcription factors as therapeutic targets in human diseases","volume":"43","author":"Orea-Soufi","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jep.2024.119238_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jep.2024.119238_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baq020","article-title":"GeneCards Version 3: the human gene integrator","volume":"2010","author":"Safran","year":"2010","journal-title":"Database"},{"key":"10.1016\/j.jep.2024.119238_bib27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bbrc.2009.02.078","article-title":"The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription","volume":"381","author":"Shlomai","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jep.2024.119238_bib28","first-page":"2","article-title":"Clinical effect evaluation of hugan detoxification decoction combined with interferon in the treatme","volume":"6","author":"Sun","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jep.2024.119238_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cld.728","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"12","author":"Terrault","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jep.2024.119238_bib30","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jep.2024.119238_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112782","article-title":"Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK\/STAT signal pathway","volume":"257","author":"Wang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2024.119238_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbrc.2017.03.171","article-title":"miR-101 suppresses HBV replication and expression by targeting FOXO1 in hepatoma carcinoma cell lines","volume":"487","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jep.2024.119238_bib33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/acel.12479","article-title":"Characterization of the direct targets of FOXO transcription factors throughout evolution","volume":"15","author":"Webb","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.jep.2024.119238_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.carbpol.2016.01.065","article-title":"Anti-HBV activity and mechanism of marine-derived polyguluronate sulfate (PGS) in vitro","volume":"143","author":"Wu","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jep.2024.119238_bib35","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.apsb.2021.03.024","article-title":"A comprehensive review of integrative pharmacology-based investigation: a paradigm shift in traditional Chinese medicine","volume":"11","author":"Xu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jep.2024.119238_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.964469","article-title":"A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology","volume":"12","author":"Yin","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jep.2024.119238_bib37","first-page":"1126","article-title":"Study on clinical efficacy of Huagan Jiedu decoction on patients with chronic hepatitis B and effects of peripheral blood T lymphocytes, IL-6 and GP73","volume":"28","author":"Yuan","year":"2022","journal-title":"J. Basic Chin. Med."},{"key":"10.1016\/j.jep.2024.119238_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.jep.2024.119238_bib39","first-page":"107","article-title":"Release mechanism and pharmacodynamics of entecavir micro spheres","volume":"37","author":"Zhang","year":"2024","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.jep.2024.119238_bib40","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.23384","article-title":"Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review","volume":"51","author":"Zhang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2024.119238_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1273031","article-title":"Convergent application of traditional Chinese medicine and gut microbiota in ameliorate of cirrhosis: a data mining and Mendelian randomization study","volume":"13","author":"Zhou","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037887412401537X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037887412401537X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:25:53Z","timestamp":1787847953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037887412401537X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":41,"alternative-id":["S037887412401537X"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2024.119238","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral activity of HuaganJiedu decoction (HGJDD) against hepatitis B virus (HBV) through FOXO4\/ERK\/HNF4\u03b1 signal pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2024.119238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119238"}}